alexa The Protective Effects Of GABA On Human Islet Cells
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Gerald J Prud?homme
ScientificTracks Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.026
In previous studies we found that the administration of gamma-aminobutyric acid (GABA) prevented type 1 diabetes (T1D) in three preclinical models. Furthermore, it induced beta-cell regeneration following the streptozotocin-induced depletion of these cells. Interestingly, many of these beneficial effects were accompanied by strong anti-inflammatory and immunosuppressive activities. Thus, we observed that GABA has stimulatory effects on murine islet beta cells but, in contrast, inhibitory effects on immune cells. Because human and murine cells can respond in considerably different ways, we proceeded to analyze the effects of GABA on human cells. We found that human beta cells respond to GABA in a manner similar to the murine cells. Notably, it markedly improved the survival of islet cells in culture. It protected these cells against apoptosis induced by cytokines and immunosuppressive drugs such as rapamycin and tacrolimus (FK506). We examined several potential mechanisms and discovered that it inhibits activation of NF-kB, and we identified a likely molecular mechanism for this action. In vivo, GABA also reduced beta-cell apoptosis following human islet transplantation into immunodeficient mice, and it stimulated the proliferation of these cells. Because T1D is an autoimmune disease, we also examined the response of human immune cells. GABA exerted inhibitory effects on T lymphocytes similar to those previously reported in mice, and this was dependent on the type A GABA receptor. Importantly, as in islet cells, it suppressed NF-kB activation. We documented that it blocks one of the earliest events in T-cell activation, i.e., calcium influx. Conclusion: GABA ameliorated human islet-cell survival considerably, and had a major inhibitory action on human immune cells. The inhibition of canonical NF-kB activation appears to be one of its most important effects, at least in the context of T1D and islet transplantation. Indeed, activation of this pathway is harmful to islet cells, and promotes autoimmune or alloreactive responses. Our findings suggest that GABA may be an effective therapeutic agent in diabetes.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version